EcoDrugPlus

Leukotriene A4 Hydrolase

Ensembl ID : ENSMMNG00015013417
Gene Symbol: LTA4H
3 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor 2

Ensembl ID : ENSMMNG00015015762
Gene Symbol: LTB4R2
3 Cross references
236 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSMMNG00015005608
Gene Symbol: KDM1A
3 Cross references
213 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSMMNG00015019701
Gene Symbol: LOXL2
3 Cross references
287 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSMMNG00015004692
Gene Symbol: MIF
3 Cross references
218 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSMMNG00015013715
Gene Symbol: MST1R
1 Cross references
266 Possible Orthologues:

Maltase-Glucoamylase

Ensembl ID : ENSMMNG00015010883
Gene Symbol: MGAM
3 Cross references
312 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSMMNG00015015906
Gene Symbol: MMP1
3 Cross references
352 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSMMNG00015015808
Gene Symbol: MMP13
3 Cross references
200 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSMMNG00015010687
Gene Symbol: MMP14
3 Cross references
269 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSMMNG00015009342
Gene Symbol: MMP2
3 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSMMNG00015015864
Gene Symbol: MMP3
1 Cross references
493 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).